Mammoth Biosciences partners with GSK to develop handheld CRISPR-based COVID-19 test

California-based Mammoth Biosciences has signed a powerful partner for its development of a CRISPR-based test for COVID-19, which would aim to delivery accurate, fast results using a handheld, disposable testing platform. Mammoth Biosciences will be using its DETECTR...

Everylwell gains first FDA authorization for a standalone at-home COVID-19 test sample collection kit

Everlywell was one of the first startups to announce that it was working on a self-administered, at-home COVID-19 diagnostic kit, but it initially sought out to ship kits before regulators made clear that this was not in line with its guidelines. Everlywell then...

FDA authorizes a ventilator developed by NASA’s JPL for emergency use in COVID-19 treatment

The U.F. Food and Drug Administration (FDA) has authorized a new ventilator designed by engineers working at NASA’s Jet Propulsion Laboratory, for emergency use as outlined in the agency’s COVID-19 guidelines. The ventilator, which has an acronym because this is NASA...

FDA reiterates risks of antimalarial drug use for COVID-19, as study into efficacy ends early due to deaths

The U.S. Food and Drug Administration (FDA) has issued a new warning about the known side effects of hydroxychrloroquine and chloroquine, two antimalarial drugs (also used in the treatment of chronic rheumatoid arthritis and lupus), on the same day that a group of...
Report: HHS Put Aide Nicknamed the ‘Dog Breeder,’ an Actual Dog Breeder, in Charge of Virus Response

Report: HHS Put Aide Nicknamed the ‘Dog Breeder,’ an Actual Dog Breeder, in Charge of Virus Response

Health and Human Services Secretary Alex Azar appointed an aide with “minimal public health experience” and who had spent the six years prior to joining the agency running a dog breeding business to head its coronavirus response in mid-January, Reuters reported on...

LabCorp’s at-home COVID-19 test kit is the first to be authorized by the FDA

LabCorp’s at-home COVID-19 test, which is called ‘Pixel,’ has received the first Emergency Use Authorization (EUA) for such a test missed by the U.S. Food and Drug Administration (FDA). The test is an at-home collection kit, which provides sample collection materials...